Back to trial detailsIntake questionnaire
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Applying to Center for Clinical Studies - Houston · Houston, Texas
Answer a few short questions to share with the research team.
0 of 4 answered